
Anthropic released two fifth-generation Claude models: Claude Fable 5 (available now through Claude API and enterprise plans) and Claude Mythos 5 (limited to select partners and US government cybersecurity programs). Fable 5 scores 80.3 percent on SWE-Bench Pro and 29.3 percent on FrontierCode, compared with Claude Opus 4.8's 69.2 percent and 13.4 percent respectively.
Fable 5 uses AI classifiers to flag requests flagged as dangerous in cybersecurity, biology and chemistry, and model distillation, automatically routing them to the weaker Claude Opus 4.8 model; over 95 percent of sessions are unaffected. In cyber tests, Fable 5 scored zero percent success rate on offensive tasks.
Mythos 5 sped up parts of the drug design process by 10x according to Anthropic's internal protein design experts, and produced novel molecular biology hypotheses that Anthropic's scientists preferred over Opus-class models about 80 percent of the time in blinded comparisons. Both models cost $10 per million input tokens and $50 per million output tokens.
Summaries like this, in your inbox every morning.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
In Q2, billionaires or their funds sold six 'Magnificent Seven' AI stocks

Nvidia was rising early Friday, even as the wider chip sector kept falling, Barron's reported

ElevenLabs completed a $300 million employee tender at a $22 billion valuation, and co-founder Mati Staniszews…

On October 15, OpenAI announced the Rosalind Academic Plan, giving approved US university labs free access to…

Neostellar Capital principal Evan Schlossman said CoreWeave's $103.7 billion in remaining performance obligati…

A Qiita article compared automated red-teaming methods for LLM apps — GCG, PAIR, and TAP — using mock implemen…
